PEX168 or placebo
PEX168-I-06
Phase 2 small_molecule completed
Quick answer
PEX168 or placebo for Type 2 Diabetes is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Type 2 Diabetes
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed